Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Xtant Medical Holdings, Inc. (XTNT)
|
Add to portfolio |
|
|
|
| Price: |
$0.64
| | Metrics |
| OS: |
108.9
|
M
| |
|
|
| Market cap: |
$69.7
|
M
| |
|
|
|
Net debt:
|
$19.6
|
M
| |
|
|
|
EV:
|
$89.3
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 58.0 | 55.3 | 53.3 | 64.7 | 72.2 | 82.6 | 90.0 | 59.3 |
| Revenue growth | 4.9% | 3.6% | -17.5% | -10.4% | -12.6% | -8.2% | 51.7% | 68.0% |
| Cost of goods sold | 25.8 | 22.8 | 18.9 | 22.2 | 28.7 | 32.5 | 27.7 | 20.3 |
| Gross profit | 32.1 | 32.5 | 34.4 | 42.5 | 43.5 | 50.1 | 62.3 | 39.1 |
| Gross margin | 55.4% | 58.8% | 64.5% | 65.7% | 60.2% | 60.6% | 69.2% | 65.9% |
| Selling, general and administrative | | | | | | | | |
| Sales and marketing | 22.5 | 21.0 | 21.0 | 26.5 | 31.5 | 40.5 | 44.1 | 28.7 |
| Research and development | 0.9 | 0.9 | 0.7 | 0.9 | 1.7 | 2.4 | 3.4 | 2.5 |
| General and administrative | 15.5 | 14.4 | 13.5 | 17.3 | 14.3 | 15.2 | 15.8 | 13.0 |
| EBITA | -6.7 | -3.9 | -0.7 | -2.2 | -5.5 | -11.1 | -2.4 | -3.7 |
| EBITA margin | -11.5% | -7.0% | -1.2% | -3.3% | -7.7% | -13.5% | -2.6% | -6.3% |
| Amortization of intangibles | 0.1 | | 0.1 | 0.1 | 3.4 | 4.6 | 4.5 | 3.4 |
| EBIT | -6.8 | -3.9 | -0.8 | -2.3 | -9.0 | -15.8 | -6.9 | -7.2 |
| EBIT margin | -11.7% | -7.0% | -1.4% | -3.5% | -12.4% | -19.1% | -7.6% | -12.1% |
| Pre-tax income | -8.4 | -4.8 | -6.7 | -8.1 | -70.1 | -52.4 | -19.4 | -19.7 |
| Income taxes | 0.1 | 0.0 | 0.3 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 |
| Tax rate | | 0.0% | | | 0.0% | 0.0% | | 0.0% |
| Net income | -8.5 | -4.8 | -7.0 | -8.2 | -70.1 | -52.4 | -19.5 | -2.2 |
| Net margin | -14.6% | -8.8% | -13.2% | -12.7% | -97.1% | -63.4% | -21.7% | -3.7% |
| |
| Diluted EPS | ($0.09) | ($0.06) | ($0.25) | ($0.62) | ($5.97) | ($34.76) | ($18.46) | ($0.24) |
| Shares outstanding (diluted) | 94.1 | 85.5 | 28.5 | 13.2 | 11.7 | 1.5 | 1.1 | 9.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|